Cushman & Wakefield
CWK NYSE Real Estate Services Financials FY2016βFY2025
Cushman & Wakefield's revenue rose 8.9% to $10.3 billion in fiscal 2025. Its operating margin was 4.4%, up from 3.6% a year earlier. Free cash flow was $293 million, up 75.5%. The diluted share count rose 0.8%.
What Cushman & Wakefield does
No business description yet.
- Legal name
- Cushman & Wakefield Ltd.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628369-26-000008
0001628369
Revenue and margins
Cushman & Wakefield had $10.3B of revenue in fiscal 2025, up 8.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $293M in fiscal 2025, 2.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cushman & Wakefield returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 0.8%.
Value Cushman & Wakefield yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.0B and divides by 234.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 39.4x Β· peers 88.5x Β· sector 27.8x.
Balance sheet
Cash, debt and the ratios that show how comfortably Cushman & Wakefield can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $771M | $645M | $768M | $793M | $784M |
| Debt incl. finance leases | $3.3B | $3.3B | $3.3B | $3.1B | $2.8B |
| Net debt / EBITDA | 3.7x | 3.8x | 7.2x | 4.9x | 3.6x |
| Debt / equity | 2.3x | 2.0x | 2.0x | 1.8x | 1.4x |
| Interest coverage | 2.8x | 2.8x | 0.7x | 1.5x | 2.1x |
| Current ratio | 1.2x | 1.2x | 1.2x | 1.2x | 1.1x |
| Quick ratio | 1.2x | 1.2x | 1.2x | 1.2x | 1.1x |
| Total assets | $7.9B | $7.9B | $7.8B | $7.5B | $7.7B |
| Total liabilities | $6.4B | $6.3B | $6.1B | $5.8B | $5.7B |
| Shareholders' equity | $1.4B | $1.7B | $1.7B | $1.8B | $2.0B |
| Net debt (β = net cash) | $2.5B | $2.6B | $2.5B | $2.3B | $2.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$1.0M
2 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Nathaniel RobinsonSee Remarks | Sold | 12,500 | $13.39 | $0.2M | Form 4 |
| Aug 13, 2026 | Laurida SayedSee Remarks | Sold | 16,000 | $13.88 | $0.2M | Form 4 |
| Jun 4, 2026 | Nathaniel RobinsonSee Remarks | Sold | 24,828 | $13.25 | $0.3M | Form 4 |
| May 12, 2026 | Nathaniel RobinsonSee Remarks | Sold | 10,000 | $13.52 | $0.1M | Form 4 |
| Mar 3, 2026 | Nathaniel RobinsonSee Remarks | Sold | 10,000 | $13.50 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 4 / 8 | 6 / 8 | 5 / 8 |
| Accruals ratio | β2.4% | β1.0% | β3.3% |
| Altman Z'' | 0.34 | 0.51 | 0.59 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Cushman & Wakefield CWK | $2.8B | 8.9% | 4.4% | 2.9% | 8.8% | 39.4x | 5 | |
| Compass COMP | $8.2B | 23.7% | β0.9% | 2.9% | β | 162.5x | β | Compare β |
| Jones Lang LaSalle JLL | $14.1B | 11.5% | 4.2% | β | 11.6% | 14.4x | 8 | Compare β |
| Newmark Group NMRK | $2.9B | 20.3% | 7.1% | 4.3% | 8.6% | 14.4x | 7 | Compare β |
| CoStar Group CSGP | $13.7B | 18.7% | β2.2% | 3.8% | β0.6% | 188.4x | 5 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $6.2B | $6.9B | $8.2B | $8.8B | $7.8B | $9.4B | $10.1B | $9.5B | $9.4B | $10.3B |
| Operating income | β$295M | β$171M | $12.6M | $187M | β$53.1M | $497M | $535M | $206M | $339M | $453M |
| Interest expense | $172M | $183M | $229M | $151M | $164M | $180M | $193M | $281M | $230M | $216M |
| Pretax income | β$459M | β$342M | β$211M | $42.8M | β$177M | $340M | $338M | β$30.0M | $176M | $114M |
| Income tax | β$24.3M | β$121M | β$25.0M | $42.6M | $43.9M | $89.9M | $142M | $5.4M | $44.5M | $26.0M |
| Net income | β$434M | β$221M | β$186M | $0.2M | β$221M | $250M | $196M | β$35.4M | $131M | $88.2M |
| Diluted EPS | β$3.07 | β$1.54 | β$1.09 | $0.00 | β$1.00 | $1.10 | $0.86 | β$0.16 | $0.56 | $0.38 |
| Diluted shares | 0.14B | 0.14B | 0.17B | 0.22B | 0.22B | 0.23B | 0.23B | 0.23B | 0.23B | 0.23B |
| Cash flow | ||||||||||
| Cash from operations | β$335M | $4.4M | β$2.2M | $269M | β$38.2M | $550M | $49.1M | $152M | $208M | $340M |
| Capital expenditure | $77.3M | $129M | $84.2M | $80.3M | $41.0M | $53.8M | $50.7M | $51.0M | $41.0M | $47.4M |
| Free cash flow | β$412M | β$125M | β$86.4M | $189M | β$79.2M | $496M | β$1.6M | $101M | $167M | $293M |
| Depreciation and amortization | $261M | $271M | $290M | $297M | $264M | $172M | $147M | $146M | $122M | $104M |
| Stock-based compensation | $49.0M | $52.4M | $81.9M | $61.3M | $42.0M | $58.2M | $40.3M | $54.1M | $35.6M | $58.2M |
| Acquisitions | $57.1M | $99.9M | $35.5M | $276M | $109M | $7.0M | $32.8M | $0.0M | $0.0M | $4.9M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $382M | $406M | $895M | $813M | $1.1B | $771M | $645M | $768M | $793M | $784M |
| Total debt | β | $2.8B | $2.7B | $2.7B | $3.3B | $3.3B | $3.3B | $3.2B | $3.0B | $2.7B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $20.3M | $19.0M | $23.2M | $39.6M | $45.9M | $36.4M | $35.7M |
| Current assets | β | $1.9B | $2.7B | $2.9B | $2.9B | $2.8B | $2.8B | $2.8B | $2.7B | $2.8B |
| Current liabilities | β | $2.0B | $2.0B | $2.3B | $2.1B | $2.4B | $2.4B | $2.4B | $2.3B | $2.6B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | β | $304M | $314M | $299M | $236M | $195M | $173M | $164M | $136M | $133M |
| Total assets | β | $5.8B | $6.5B | $7.2B | $7.3B | $7.9B | $7.9B | $7.8B | $7.5B | $7.7B |
| Total liabilities | β | $5.3B | $5.2B | $5.9B | $6.2B | $6.4B | $6.3B | $6.1B | $5.8B | $5.7B |
| Shareholders' equity | $586M | $499M | $1.4B | $1.3B | $1.1B | $1.4B | $1.7B | $1.7B | $1.8B | $2.0B |
| Margins | ||||||||||
| Operating margin | β4.8% | β2.5% | 0.2% | 2.1% | β0.7% | 5.3% | 5.3% | 2.2% | 3.6% | 4.4% |
| EBITDA margin | β0.6% | 1.4% | 3.7% | 5.5% | 2.7% | 7.1% | 6.8% | 3.7% | 4.9% | 5.4% |
| Net margin | β7.0% | β3.2% | β2.3% | 0.0% | β2.8% | 2.7% | 1.9% | β0.4% | 1.4% | 0.9% |
| FCF margin | β6.6% | β1.8% | β1.1% | 2.2% | β1.0% | 5.3% | β0.0% | 1.1% | 1.8% | 2.9% |
| Returns | ||||||||||
| Return on capital | β | β | 0.3% | 3.0% | β1.3% | 10.1% | 7.6% | 3.8% | 6.2% | 8.8% |
| Return on capital employed | β | β | 0.3% | 4.0% | β1.1% | 9.3% | 9.7% | 3.8% | 6.4% | 8.8% |
| Return on equity | β | β | β20.0% | 0.0% | β18.4% | 19.7% | 12.6% | β2.1% | 7.7% | 4.8% |
| Return on assets | β | β | β3.0% | 0.0% | β3.0% | 3.3% | 2.5% | β0.5% | 1.7% | 1.2% |
| Growth | ||||||||||
| Revenue growth | β | 11.4% | 18.7% | 6.5% | β10.4% | 19.7% | 7.6% | β6.1% | β0.5% | 8.9% |
| Net income growth | β | β | β | β | β110,350.0% | β | β21.4% | β118.0% | β | β32.8% |
| EPS growth | β | β | β | β | β | β | β21.8% | β118.6% | β | β32.1% |
| FCF growth | β | β | β | β | β141.9% | β | β100.3% | β | 65.0% | 75.5% |
| Share count change | β | 1.8% | 19.0% | 31.1% | β1.7% | 2.6% | 0.7% | β0.5% | 2.6% | 0.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | 24.4x | 5.9x | 3.8x | 10.4x | 3.7x | 3.8x | 7.2x | 4.9x | 3.6x |
| Debt / equity | β | 5.7x | 2.0x | 2.0x | 3.0x | 2.3x | 2.0x | 2.0x | 1.8x | 1.4x |
| Interest coverage | β1.7x | β0.9x | 0.1x | 1.2x | β0.3x | 2.8x | 2.8x | 0.7x | 1.5x | 2.1x |
| Current ratio | β | 1.0x | 1.4x | 1.2x | 1.4x | 1.2x | 1.2x | 1.2x | 1.2x | 1.1x |
| Quick ratio | β | 1.0x | 1.4x | 1.2x | 1.4x | 1.2x | 1.2x | 1.2x | 1.2x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.2% | 1.9% | 1.0% | 0.9% | 0.5% | 0.6% | 0.5% | 0.5% | 0.4% | 0.5% |
| Stock comp / revenue | 0.8% | 0.8% | 1.0% | 0.7% | 0.5% | 0.6% | 0.4% | 0.6% | 0.4% | 0.6% |
| Payouts / FCF | β | β | β | 0.0% | β | 0.0% | β | 0.0% | 0.0% | 0.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | 5.0 | 3.0 | 6.0 | 4.0 | 4.0 | 6.0 | 5.0 |
| Altman Z'' | β | β0.8 | 0.4 | 0.3 | 0.2 | 0.5 | 0.6 | 0.3 | 0.5 | 0.6 |
| Accruals ratio | β | β | β3.0% | β3.9% | β2.5% | β3.9% | 1.9% | β2.4% | β1.0% | β3.3% |
Source: SEC EDGAR XBRL filings (CIK 0001628369). Data updated October 12, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.